New 2025 guidelines set standards for PH and DVT management.
Guidelines provide evidence-based recommendations for managing pulmonary hypertension (PH) and thrombosis, which are crucial for improving patient outcomes. The document outlines new guidelines for managing PH and pulmonary embolism (PE)/deep vein thrombosis (DVT), though detailed findings are not available. Healthcare providers must integrate new recommendations into practice to optimize treatment strategies for PH and PE/DVT. Stay updated with the latest guidelines for managing PH and thrombotic conditions.
Authors: Tamura Y, Kusunose K, Yamashita Y, Akagi T, Atsukawa M, Fukumoto Y, Goda A, Goto S, Hatano M, Ikeda M, Ishida K, Kataoka M, Kuwana M, Matsubara H, Mo M, Nagaoka T, Ogo T, Okada Y, Sakao S, Sawada H, Shinke T, Tanabe N, Yamada N, Yamagishi H, Yano S, Abe K, Adachi S, Hosokawa K, Ikeda N, Inami T, Jinzaki M, Kato M, Kitai T, Kogaki S, Koizumi J, Morio Y, Nishizaki M, Ogihara Y, Ohta-Ogo K, Shigematsu K, Sugimura K, Tamura Y, Taniguchi Y, Tsujino I, Uchida K, Yamamoto T, Yao A, Yaoita N, Emoto N, Kitaoka H, Nakamura M, Ogino H, Satoh T, Watanabe H, Japanese Circulation Society and Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group
Citation: Tamura Y, Kusunose K, Yamashita Y, et al. JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis. Circulation journal : official journal of the Japanese Circulation Society. 2026;90(10):1484-1570. doi:10.1253/circj.CJ-25-1144
Article Links: PubMed · Journal / DOI
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.
Become a Subscriber →